News

Rice University researchers have developed a new genome editing tool by programming a modified CRISPR/Cas9 complex to target specific histones, epigenetic proteins that keep DNA in order, opening the door to potential new therapies for cancer and other diseases.

University of Copenhagen researchers have developed an AI tool that can predict with 90 percent accuracy which patients will die from COVID-19, as well as which patients will need a ventilator while hospitalized. Using data from almost 4,000 COVID-19 patients in Denmark, the tool was trained to find patterns in patients' medical histories. The tool would be helpful in prioritizing vaccine administration and determining the number of ventilators that might be necessary for each hospital.

Leading Latin American medical research organization Oswaldo Cruz Foundation (Fiocruz) is conducing a study on the new COVID-19 variant spreading across Brazil. According to research studies, 91 percent of cases found in Amazonas are linked to the new variant, indicating it is more transmissible.

Faced with an impossible challenge, researchers developed ways to test and distribute Ebola vaccines to villages with no power, all while being stored at -80 degrees Celsius.

A Harvard Engineer and technology expert has warned the next global pandemic could be the result of a bioterrorist attack, thanks to advances in accessible, inexpensive genetic engineering methods. Preparation and analysis of lessons learned could prove invaluable to combatting a man-made engineered virus.

Preventing the introduction of harmful pathogens on farms remains crucial to maintaining a healthy swine population. Proactive methods can be used to ensure proper biosecurity measures are taken, this article shares more details about how farmers can institute biosecurity best practices to prevent disease.

Sometimes, innovative solutions to vaccine distribution are needed. Read more about how shortages of yellow fever and polio have encouraged the discovery of ways to stretch vaccine doses and inoculation initiatives.

With their constant threat to livestock, transboundary and emerging diseases could benefit from evolving biosafety and biosecurity measures. Scientists are using next-generation sequencing to mitigate risks and detect disease.

A recent study found the combination of bamlanivimab and etesevimab delivered early in the onset of SARS-CoV-2 disease resulted significantly lower viral loads at day 11 in patients than those who received a placebo. This effect was not seen in patients who were provided only one of the drugs.

On Saturday, January 2, there was a fire at the Serum Institute of India's facilities in Pune. This facility is the world's largest vaccine manufacturer. The company reports that vaccine production would is not affected. This facility is producing Oxford-AstraZeneca COVID-19 vaccine.